摘要

Vascular smooth muscle cells (VSMCs) that function as synthetic units play important roles in cardiovascular diseases. Extracellular nucleotides, such as ATP, have been shown to act via activation of P-2 purinoceptors implicated in various inflammatory diseases, we hypothesized that extracellular nucleotides contribute to vascular diseases via up-regulation of inflammatory proteins, including cyclooxygenase-2 (COX-2) and cytosolic phospholipase A(2) (cPLA(2)) in VSMCs. However, the mechanisms of ATP-induced cPLA(2) and COX-2 expression and PGE(2) synthesis remain largely unclear. We showed that pretreatment with the inhibitors of STAT3 (CBE), NADPH oxidase [diphenyleneiodonium chloride (DPI) or apocynin (APO)], ROS [N-acetyl-L-cysteine (NAC)], and PKC (Ro-318220, G66983, or Rottlerin) or transfection with siRNAs of STAT3 and p47(phox) markedly inhibited ATP gamma S-induced cPLA(2) and COX-2 mRNA/protein expression and promoter activity and PGE(2) secretion. ATP gamma S further stimulated PKC, p47(phox), and STAT3 translocation. Moreover, ATP gamma S-induced STAT3 phosphorylation and translocation was inhibited by pretreatment with the inhibitors of PKC, NADPH oxidase, and ROS. ATP gamma S enhanced NADPH oxidase activity and ROS generation in VSMCs, which were reduced by pretreatment with Ro-318220, G66983, or Rottlerin. Finally, we found that ATP gamma S significantly induced cyclin D1 expression and VSMCs proliferation, which were inhibited by pretreatment with NAC, APO, DPI, Ro-318220, G66983, Rottlerin, or CBE or transfection with siRNAs of COX-2 and cyclin D1. We also demonstrated that ATP gamma S induced cyclin D1 expression via a PGE(2)-dependent pathway. These results suggested that ATRyS-induced cPLA(2)/COX-2 expression and PGE(2) secretion is mediated through a PKC/NADPH oxidase/ROS/STAT3-dependent pathway in VSMCs.

  • 出版日期2013-4-1
  • 单位长春大学